Stories > Boston Scientific's Q4 Results Exceed Expectations

Boston Scientific's Q4 Results Exceed Expectations

BMY Stock's Undervaluation

Biogen's Q3 Report and Reata Acquisition

BlackBerry's Loss and Business Separatio...

Allstate Surpasses Q1 Earnings Forecast

Altria Affirms 2024 Earnings Outlook

Analysts Cut Forecasts on CoStar Group